Avoro Capital Advisors LLC Biocryst Pharmaceuticals Inc Transaction History

Avoro Capital Advisors LLC

$6.18 Billion
Q1 2025

A detailed history of Avoro Capital Advisors LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 8,700,000 shares of BCRX stock, worth $92.1 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

8,700,000

Previous 11,865,000 26.68%

Holding current value

$92.1 Million

Previous $89.2 Million 26.87%

% of portfolio

1.06%

Previous 1.3%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$7.06 - $9.39 $22.3 Million - $29.7 Million	-3,165,000 Reduced 26.68%	8,700,000 $65.3 Million
Q3 2024 Nov 14, 2024	SELL	$6.41 - $8.69 $4.52 Million - $6.13 Million	-705,000 Reduced 5.61%	11,865,000 $90.2 Million
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $1.98 Million - $3.26 Million	-480,000 Reduced 3.68%	12,570,000 $77.7 Million
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $7.47 Million - $10.2 Million	1,500,000 Added 12.99%	13,050,000 $78.2 Million
Q3 2023 Nov 14, 2023	SELL	$6.71 - $7.92 $3.39 Million - $4 Million	-505,000 Reduced 4.19%	11,550,000 $81.8 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $11.4 Million - $14.4 Million	1,635,000 Added 15.69%	12,055,000 $84.9 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $10.9 Million - $16.2 Million	1,370,000 Added 15.14%	10,420,000 $86.9 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $27.5 Million - $37.8 Million	2,550,000 Added 39.23%	9,050,000 $114 Million
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $36.5 Million - $82.7 Million	4,625,000 Added 246.67%	6,500,000 $68.8 Million
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $21.7 Million - $37.1 Million	1,875,000 New	1,875,000 $30.5 Million
Q1 2018 May 15, 2018	SELL	$4.35 - $5.82 $1.48 Million - $1.98 Million	-340,821 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $5.98 Million - $7.66 Million	-1,437,704 Reduced 80.84%	340,821 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $7.29 Million - $10.6 Million	1,778,525	1,778,525 $9.32 Million

Others Institutions Holding BCRX

# of Institutions

292

Shares Held

177M

Call Options Held

721K

Put Options Held

489K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.97B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Biocryst Pharmaceuticals Inc Transaction History